Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Moreover, peptide analogues that are unimolecular co-agonists of both GLP-1R and GCGR are currently in clinical development for the treatment of T2D, obesity and non-alcoholic steatohepatitis (NASH) 2,3,5,6,7
JCI Insight 4(5):e126742
Physiological Reviews , 87(4), 14091439
Description A research-grade lyophilized peptide blend containing Tesamorelin, a synthetic GHRH analog, and Ipamorelin, a selective growth hormone secretagogue
Khch hng nh gi Tng quan 0.0 (0 nh gi) Tt c hnh nh (0): Cha c hnh nh nh gi Lc theo: Cha c nh gi no cho sn phm ny.
US$ 29.45
US$ 23.93
US$ 24.85
US$ 20.89
US$ 27.71
US$ 20.38
US$ 28.13
US$ 23.42
